Literature DB >> 9015699

Serum levels of androstenedione, testosterone and dehydroepiandrosterone sulfate in patients with premature ovarian failure to age-matched menstruating controls.

A N Elias1, M R Pandian, F J Rojas.   

Abstract

Serum concentrations of androstenedione, testosterone and dehydroepiandrosterone sulfate (DHEAS) were measured in 29 patients with premature ovarian failure (POF) and an identical number of age-matched normal control subjects. The study was aimed at determining possible differences in androgen concentrations of ovarian and adrenal origin in POF patients and age-matched normal menstruating controls. Serum testosterone and DHEAS concentrations in the 2 populations were not significantly different. The serum androstenedione concentration in the POF patient group (3,077.50 +/- 1,122.33 pmol/l) was significantly lower than in age-matched normal control subjects (4,167.70 +/- 1,381.09 pmol/l, p < 0.005), possibly reflecting the loss of ovarian androstenedione secretion and/or a subtle defect in adrenal steroidogenic capacity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9015699     DOI: 10.1159/000291817

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  3 in total

Review 1.  Hormone replacement therapy in young women with primary ovarian insufficiency and early menopause.

Authors:  Shannon D Sullivan; Philip M Sarrel; Lawrence M Nelson
Journal:  Fertil Steril       Date:  2016-12       Impact factor: 7.329

2.  Adrenocortical production is associated with higher levels of luteinizing hormone in nonobese women with polycystic ovary syndrome.

Authors:  Luciana Tock; Gláucia Carneiro; Andrea Z Pereira; Sérgio Tufik; Maria Teresa Zanella
Journal:  Int J Endocrinol       Date:  2014-05-07       Impact factor: 3.257

3.  Serum androgen profiles in women with premature ovarian insufficiency: a systematic review and meta-analysis.

Authors:  Midhun Soman; Li-Cong Huang; Wen-Hui Cai; Jun-Bi Xu; Jun-Yao Chen; Ren-Ke He; Heng-Chao Ruan; Xiang-Rong Xu; Zhi-Da Qian; Xiao-Ming Zhu
Journal:  Menopause       Date:  2019-01       Impact factor: 2.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.